Previous 10 | Next 10 |
2024-06-24 09:37:14 ET Fool.com contributor Parkev Tatevosian evaluates Hims & Hers Health (NYSE: HIMS) stock for long-term investors. *Stock prices used were the afternoon prices of June 20, 2024. The video was published on June 22, 2024. Continue reading ...
2024-06-24 08:30:00 ET Summary After a parabolic run in recent months, HIMS stock took a double-digit plunge last week in an apparent loss of technical momentum. While its technical correction may lead to a deeper pullback in the near term, Hims & Hers' robust business momentu...
2024-06-21 09:44:16 ET More on Hims & Hers Health Hims & Hers: The Undervalued Gem Poised For Growth Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead Hims & Hers: Ready For Takeoff Hims & Hers cut to Neutra...
2024-06-20 13:27:30 ET More on iShares Russell 3000 ETF: IWV: Future Performance Will Likely Remain Slightly Inferior To The S&P 500 Index Layoffs mentions by Russell 3000 companies are elevated but trending lower vs history The big risk of AI spending is margin ...
2024-06-18 03:05:48 ET Summary As of this article being written, Hims & Hers Health is up around 33% since the announcement that they will offer GLP-1 Injections for as low as $199 a month. Reports that the company has already started shipping out injections to subscribers. ...
2024-06-13 16:00:00 ET Summary HIMS has proven that a telehealth platform can remain relevant in a rapidly changing landscape, by opting to cater to the retail healthcare market through customized prescription/ over-the-counter medications. This is attributed to its in-house pharm...
Hims & Hers Health, Inc. (NYSE: HIMS) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.97% on the day to $23.45. Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The com...
2024-06-10 15:47:28 ET Summary Hims & Hers has rallied substantially this year as it started to show its profitability chops. Despite guiding for a >$1 billion annualized revenue scale in 2024, the company is still expected to grow revenue north of 40%+ and have 80%+ pro fo...
2024-06-10 12:06:11 ET Summary Hims & Hers stock has easily outperformed the market over the past year, surging almost 130%. Hims & Hers' personalized care platform is a critical growth driver poised to expand further. Hims & Hers is targeting the weight loss drugs...
2024-06-10 04:41:47 ET Summary Hims & Hers boasts booming revenue, but faces a commoditized business model with intense competition. High marketing expenses raise concerns about customer retention and unit economics. Decelerating revenue growth, potential margin contractio...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...
2024-07-02 11:50:00 ET There are just a little more than 30 U.S. exchange-listed companies with market caps greater than $1 billion that more than doubled in the first half of this year. It's fair to say that most of them won't repeat the feat through the final six months of 2024. It doesn'...
2024-06-29 10:00:00 ET Shares of Hims & Hers (NYSE: HIMS) fell on Thursday after a short report was published by a short-seller. This kind of report can often send stocks lower, but is it a reason to panic or a buying opportunity? In this video, Travis Hoium digs into the report...